reviewTop 1% cited
Galantamine
Drugs · 2000 · Vol. 60(5) · pp. 1095–1122
Chemical synthesis and alkaloidsCholinesterase and Neurodegenerative DiseasesNicotinic Acetylcholine Receptors StudyGalantamineAcetylcholinesteraseMedicineAdverse effectCholinesterasePlaceboPharmacologyCholinergicInternal medicineAnesthesia
MeSH terms
AcetylcholinesteraseAlzheimer DiseaseAnimalsCholinesterase InhibitorsClinical Trials as TopicCognitionDisease Models, AnimalGalantamineHumans
Citations
376
FWCI
11.85
field-weighted impact
References
129
Percentile
99%
vs. same field & year
Citations per year
Cited by
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Molecules · 2020 · 2,526 citations
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
Neuropharmacology · 2020 · 1,017 citations
References
A new rating scale for Alzheimer's disease
American Journal of Psychiatry · 1984 · 4,157 citations
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
JAMA · 1997 · 4,580 citations
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Neurology · 1993 · 3,794 citations
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Science · 1993 · 9,373 citations
The Neuropsychiatric Inventory
Neurology · 1994 · 7,484 citations
The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research
Psychiatry Research · 1989 · 33,835 citations
Clinical diagnosis of Alzheimer's disease
Neurology · 1984 · 27,910 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.